Stock BLAC BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bellevue Life Sciences Acquisition Corp.

Equities

BLAC

US0791741087

Investment Holding Companies

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-22 EDT 		5-day change 1st Jan Change
10.73 USD -.--% Intraday chart for Bellevue Life Sciences Acquisition Corp. -.--% +2.19%
05-15 Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding CI

Valuation

Fiscal Period: December 2023
Capitalization 1 95.08
Enterprise Value (EV) 1 95.13
P/E ratio 210 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF 123,789,652 x
FCF Yield 0%
Price to Book -15.1 x
Nbr of stocks (in thousands) 9,055
Reference price 2 10.50
Announcement Date 4/17/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - - -
EBITDA - - - -
EBIT 1 -0.0238 -0.003308 -0.0354 -1.831
Operating Margin - - - -
Earnings before Tax (EBT) 1 -0.0238 -0.003308 -0.0354 0.9446
Net income 1 -0.0238 -0.003308 -0.0354 0.4038
Net margin - - - -
EPS 2 -0.0190 -0.002205 -0.0236 0.0500
Free Cash Flow - 0.2736 -0.273 0.7685
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - 190.33%
Dividend per Share - - - -
Announcement Date 3/12/21 4/29/22 3/31/23 4/17/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 0.24 0.41 1.09 0.06
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 0.27 -0.27 0.77
ROE (net income / shareholders' equity) - 710% 179% -20.5%
ROA (Net income/ Total Assets) - -0.4% -2.29% -6.05%
Assets 1 - 0.8223 1.545 -6.679
Book Value Per Share 2 0 -0 -0.0300 -0.6900
Cash Flow per Share 2 0.0400 0 0.0800 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 3/12/21 4/29/22 3/31/23 4/17/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
BELLEVUE LIFE SCIENCES ACQUISITION CORP. Stock Bellevue Life Sciences Acquisition Corp.
+2.19% 60.33M
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+180.51% 8.67B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.29% 983M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 883M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+26.17% 825M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.92% 665M
E7 GROUP Stock E7 Group
+9.52% 664M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ADMIRAL ACQUISITION LIMITED Stock Admiral Acquisition Limited
+9.17% 530M
CAPITOL INVESTMENT CORP. VII Stock Capitol Investment Corp. VII
-.--% 500M
Shell Companies
  1. Stock Market
  2. Equities
  3. BLAC Stock
  4. Financials Bellevue Life Sciences Acquisition Corp.